Towa Pharmaceutical Co Ltd

Improved volumes thanks to strong domestic demand for its generics and a lower-than-expected full-year R&D spend have pushed Japan’s Towa to raise its financial expectations for 2024, with the fir

Japanese generics giant Towa Pharmaceutical has delivered its annual financial results for the company’s year ended March 2024, achieving 17.4% revenue growth and a trebling of its operating profit

The consolidation of Sunsho Pharmaceutical has proved to be something of a double-edged sword for Towa Pharmaceutical Co Ltd , as the acquisition both boosted sales and sent costs soaring during Q3.

Towa Pharmaceutical has announced a major acquisition that will see it take full ownership of fellow Japanese company Sunsho Pharmaceutical from Carlyle’s CJP SP Holding company, with the takeover of